These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 15952060

  • 1. Tat mammaglobin fusion protein transduced dendritic cells stimulate mammaglobin-specific CD4 and CD8 T cells.
    Viehl CT, Tanaka Y, Chen T, Frey DM, Tran A, Fleming TP, Eberlein TJ, Goedegebuure PS.
    Breast Cancer Res Treat; 2005 Jun; 91(3):271-8. PubMed ID: 15952060
    [Abstract] [Full Text] [Related]

  • 2. A tat fusion protein-based tumor vaccine for breast cancer.
    Viehl CT, Becker-Hapak M, Lewis JS, Tanaka Y, Liyanage UK, Linehan DC, Eberlein TJ, Goedegebuure PS.
    Ann Surg Oncol; 2005 Jul; 12(7):517-25. PubMed ID: 15889213
    [Abstract] [Full Text] [Related]

  • 3. Generation of CD8+ and CD4+ T-cell response to dendritic cells genetically engineered to express the MART-1/Melan-A gene.
    Pérez-Díez A, Butterfield LH, Li L, Chakraborty NG, Economou JS, Mukherji B.
    Cancer Res; 1998 Dec 01; 58(23):5305-9. PubMed ID: 9850054
    [Abstract] [Full Text] [Related]

  • 4. Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme.
    Bondurant KL, Crew MD, Santin AD, O'Brien TJ, Cannon MJ.
    Clin Cancer Res; 2005 May 01; 11(9):3446-54. PubMed ID: 15867247
    [Abstract] [Full Text] [Related]

  • 5. Dendritic cells transduced with TAT protein transduction domain-containing tyrosinase-related protein 2 vaccinate against murine melanoma.
    Shibagaki N, Udey MC.
    Eur J Immunol; 2003 Apr 01; 33(4):850-60. PubMed ID: 12672050
    [Abstract] [Full Text] [Related]

  • 6. Recognition of HLA-A2-restricted mammaglobin-A-derived epitopes by CD8+ cytotoxic T lymphocytes from breast cancer patients.
    Jaramillo A, Narayanan K, Campbell LG, Benshoff ND, Lybarger L, Hansen TH, Fleming TP, Dietz JR, Mohanakumar T.
    Breast Cancer Res Treat; 2004 Nov 01; 88(1):29-41. PubMed ID: 15538043
    [Abstract] [Full Text] [Related]

  • 7. Addition of TAT protein transduction domain and GrpE to human p53 provides soluble fusion proteins that can be transduced into dendritic cells and elicit p53-specific T-cell responses in HLA-A*0201 transgenic mice.
    Justesen S, Buus S, Claesson MH, Pedersen AE.
    Immunology; 2007 Nov 01; 122(3):326-34. PubMed ID: 17610503
    [Abstract] [Full Text] [Related]

  • 8. Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells.
    May RJ, Dao T, Pinilla-Ibarz J, Korontsvit T, Zakhaleva V, Zhang RH, Maslak P, Scheinberg DA.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4547-55. PubMed ID: 17671141
    [Abstract] [Full Text] [Related]

  • 9. Modification of CEA with both CRT and TAT PTD induces potent anti-tumor immune responses in RNA-pulsed DC vaccination.
    Kim SG, Park MY, Kim CH, Sohn HJ, Kim HS, Park JS, Kim HJ, Oh ST, Kim TG.
    Vaccine; 2008 Nov 25; 26(50):6433-40. PubMed ID: 18812201
    [Abstract] [Full Text] [Related]

  • 10. Mammaglobin-A is a tumor-associated antigen in human breast carcinoma.
    Tanaka Y, Amos KD, Fleming TP, Eberlein TJ, Goedegebuure PS.
    Surgery; 2003 Jan 25; 133(1):74-80. PubMed ID: 12563241
    [Abstract] [Full Text] [Related]

  • 11. Induction of antigen-specific CTL by recombinant HIV trans-activating fusion protein-pulsed human monocyte-derived dendritic cells.
    Tanaka Y, Dowdy SF, Linehan DC, Eberlein TJ, Goedegebuure PS.
    J Immunol; 2003 Feb 01; 170(3):1291-8. PubMed ID: 12538688
    [Abstract] [Full Text] [Related]

  • 12. Characterization of the role of CD8+T cells in breast cancer immunity following mammaglobin-A DNA vaccination using HLA-class-I tetramers.
    Bharat A, Benshoff N, Fleming TP, Dietz JR, Gillanders WE, Mohanakumar T.
    Breast Cancer Res Treat; 2008 Aug 01; 110(3):453-63. PubMed ID: 17874294
    [Abstract] [Full Text] [Related]

  • 13. Elicitation of both CD4 and CD8 T-cell-mediated specific immune responses to HCA587 protein by autologous dendritic cells.
    Li B, He X, Pang X, Zhang H, Chen J, Chen W.
    Scand J Immunol; 2004 Nov 01; 60(5):506-13. PubMed ID: 15541044
    [Abstract] [Full Text] [Related]

  • 14. [Changes in immune function of dendritic cells infected by recombinant adenovirus containing Her2/neu gene of extracellular and transmembrane domain proteins].
    Ma SD, Luo RC, Ding ZH, Lu F, Yuan CQ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug 01; 26(8):1184-7. PubMed ID: 16939917
    [Abstract] [Full Text] [Related]

  • 15. A retrogen strategy for presentation of an intracellular tumor antigen as an exogenous antigen by dendritic cells induces potent antitumor T helper and CTL responses.
    You Z, Hester J, Rollins L, Spagnoli GC, van der Bruggen P, Chen SY.
    Cancer Res; 2001 Jan 01; 61(1):197-205. PubMed ID: 11196161
    [Abstract] [Full Text] [Related]

  • 16. Enhanced induction of telomerase-specific CD4(+) T cells using dendritic cells transfected with RNA encoding a chimeric gene product.
    Su Z, Vieweg J, Weizer AZ, Dahm P, Yancey D, Turaga V, Higgins J, Boczkowski D, Gilboa E, Dannull J.
    Cancer Res; 2002 Sep 01; 62(17):5041-8. PubMed ID: 12208759
    [Abstract] [Full Text] [Related]

  • 17. HER2-specific T-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulan.
    Kitano S, Kageyama S, Nagata Y, Miyahara Y, Hiasa A, Naota H, Okumura S, Imai H, Shiraishi T, Masuya M, Nishikawa M, Sunamoto J, Akiyoshi K, Kanematsu T, Scott AM, Murphy R, Hoffman EW, Old LJ, Shiku H.
    Clin Cancer Res; 2006 Dec 15; 12(24):7397-405. PubMed ID: 17189412
    [Abstract] [Full Text] [Related]

  • 18. In vitro stimulation of CD8 and CD4 T cells by dendritic cells loaded with a complex of cholesterol-bearing hydrophobized pullulan and NY-ESO-1 protein: Identification of a new HLA-DR15-binding CD4 T-cell epitope.
    Hasegawa K, Noguchi Y, Koizumi F, Uenaka A, Tanaka M, Shimono M, Nakamura H, Shiku H, Gnjatic S, Murphy R, Hiramatsu Y, Old LJ, Nakayama E.
    Clin Cancer Res; 2006 Mar 15; 12(6):1921-7. PubMed ID: 16551878
    [Abstract] [Full Text] [Related]

  • 19. Assessment of fusion cells from patient-derived ovarian carcinoma cells and dendritic cells as a vaccine for clinical use.
    Koido S, Nikrui N, Ohana M, Xia J, Tanaka Y, Liu C, Durfee JK, Lerner A, Gong J.
    Gynecol Oncol; 2005 Nov 15; 99(2):462-71. PubMed ID: 16137749
    [Abstract] [Full Text] [Related]

  • 20. Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.
    Mascarell L, Fayolle C, Bauche C, Ladant D, Leclerc C.
    J Virol; 2005 Aug 15; 79(15):9872-84. PubMed ID: 16014948
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.